World's Best Scientists 2026 revealed!
Jennifer G. Robinson

Jennifer G. Robinson

D-Index & Metrics

Medicine

D-Index
96
Citations
61333
World Ranking
9461
National Ranking
4881

Jennifer G. Robinson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jennifer G. Robinson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 437 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jennifer G. Robinson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jennifer G. Robinson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jennifer G. Robinson is affiliated with the University of Iowa in the United States. Their research primarily focuses on medicine, with a particular emphasis on economics and econometrics, cardiology and cardiovascular medicine, surgery, public health, environmental and occupational health, and endocrinology, diabetes, and metabolism.

Robinson's work covers several main topics, including lipoproteins and cardiovascular health, health systems, economic evaluations, quality of life, pharmaceutical economics and policy, cardiovascular health and risk factors, diabetes, cardiovascular risks, and lipoproteins, medication adherence and compliance, as well as cardiac health and mental health.

Their recent publications include:

  • Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group, 2020, Journal of the American Heart Association
  • Association of Low-Density Lipoprotein Cholesterol Levels with More than 20-Year Risk of Cardiovascular and All-Cause Mortality in the General Population, 2022, Journal of the American Heart Association
  • Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies, 2020, PLoS Medicine
  • Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy, 2021, Circulation Cardiovascular Quality and Outcomes
  • Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop, 2022, American Journal of Preventive Cardiology

Frequent co-authors working alongside Robinson include Wei Bao, Ann Marie Návar, JoAnn E. Manson, Gang Fang, and Tracy Y. Wang.

Robinson's research has appeared in various publication venues, notably UNC Libraries, Journal of the American Heart Association, Journal of Clinical Lipidology, Journal of the American College of Cardiology, and Circulation, reflecting a broad dissemination within medical and cardiovascular research domains.

Best Publications

  • 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

    Neil J Stone;Jennifer G Robinson;Alice H. Lichtenstein;C Noel Bairey Merz

  • 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

    David C. Goff;Donald M. Lloyd-Jones;Glen Bennett;Sean Coady

  • 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

    David C. Goff;Donald M. Lloyd-Jones;Faha Glen Bennett;Sean Coady

  • Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

    Jennifer G. Robinson;Michel Farnier;Michel Krempf;Jean Bergeron

  • Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association

    Frank M. Sacks;Alice H. Lichtenstein;Jason H.Y. Wu;Lawrence J. Appel

  • The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

    D I Swerdlow;M V Holmes;K B Kuchenbaecker

  • Loss-of-function mutations in APOC3, triglycerides, and coronary disease

    Jacy Crosby;Gina M. Peloso;Gina M. Peloso;Paul L. Auer;David R. Crosslin

  • HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

    Daniel I Swerdlow;David Preiss;Karoline B Kuchenbaecker;Michael Holmes

  • Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

    Anne C. Goldberg;Paul N. Hopkins;Peter P. Toth;Christie M. Ballantyne

  • Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes

    Brian A. Ference;Jennifer G. Robinson;Robert D. Brook;Alberico L. Catapano

  • Noninvasive Pulse Wave Analysis for the Early Detection of Vascular Disease

    Jay N Cohn;Stanley M Finkelstein;Gary McVeigh;Dennis Morgan

  • Optimism, Cynical Hostility, and Incident Coronary Heart Disease and Mortality in the Women’s Health Initiative

    Hilary A. Tindle;Yue-Fang Chang;Lewis H. Kuller;JoAnn E. Manson

  • Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial

    Jennifer G. Robinson;Bettina S. Nedergaard;William J. Rogers;Jonathan Fialkow

  • Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk

    Jennifer G. Robinson;Songfeng Wang;Brian J. Smith;Terry A. Jacobson

  • Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.

    Jennifer G. Robinson;Brian Smith;Nidhi Maheshwari;Helmut Schrott

  • Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.

    Eliano P Navarese;Jennifer G Robinson;Mariusz Kowalewski;Michalina Kolodziejczak

  • Cognitive Function in a Randomized Trial of Evolocumab

    Robert P. Giugliano;François Mach;Kenton Zavitz;Christopher Kurtz

  • Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

    M.S. Sabatine;R.P. Giugliano;S.D. Wiviott

  • Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study.

    Dean J. Kereiakes;Jennifer G. Robinson;Christopher P. Cannon;Christelle Lorenzato

  • HMG-COENZYME A REDUCTASE INHIBITION, TYPE 2 DIABETES, AND BODYWEIGHT: EVIDENCE FROM GENETIC ANALYSIS AND RANDOMISED TRIALS

    D Swerdlow;D Preiss;A D Hingorani;N Sattar

Frequent Co-Authors

JoAnn E. Manson
JoAnn E. Manson Harvard Medical School
Robert B. Wallace
Robert B. Wallace University of Iowa
Charles B. Eaton
Charles B. Eaton Brown University
Bruce M. Psaty
Bruce M. Psaty University of Washington
Barbara V. Howard
Barbara V. Howard MedStar Health
Christie M. Ballantyne
Christie M. Ballantyne Baylor College of Medicine
Eric Boerwinkle
Eric Boerwinkle The University of Texas Health Science Center at Houston
Charles Kooperberg
Charles Kooperberg Fred Hutchinson Cancer Research Center
Mark A. Espeland
Mark A. Espeland Wake Forest University
Alexander P. Reiner
Alexander P. Reiner University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but exploring alternative routes to traditional medical school, a variety of online degrees can open rewarding career pathways. Programs like the shortest online pmhnp programs allow students to quickly gain advanced skills as Psychiatric Mental Health Nurse Practitioners, providing essential mental health care in clinical or community settings.

Students looking for roles on the administrative side of healthcare can consider an online healthcare administration degree. These degrees prepare graduates to handle leadership, operations, and organizational challenges in hospitals and clinics.

For those seeking more advanced administrative qualifications at an accessible price, the cheapest mha online programs deliver management and policy expertise while offering significant savings on tuition.

Finally, nurses aspiring to the highest level of practice and leadership may pursue the best online bsn to dnp programs. These doctorates equip graduates for top-tier clinical, policy, and academic roles to advance patient care and healthcare systems.

Best Scientists Citing Jennifer G. Robinson

Trending Scientists

Recently Published Articles